DA Davidson Maintains Underperform on Medifast, Maintains $17.5 Price Target
Portfolio Pulse from Benzinga Newsdesk
DA Davidson analyst Linda Bolton Weiser maintains an Underperform rating on Medifast (NYSE:MED) with a $17.5 price target.
July 22, 2024 | 8:16 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
DA Davidson analyst Linda Bolton Weiser maintains an Underperform rating on Medifast with a $17.5 price target, indicating a bearish outlook.
The Underperform rating and low price target of $17.5 suggest that the analyst expects Medifast's stock to underperform in the market. This bearish outlook is likely to negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100